国家药品集中采购政策的主要利益相关者分析
x

请在关注微信后,向客服人员索取文件

篇名: 国家药品集中采购政策的主要利益相关者分析
TITLE:
摘要:
目的为更好地执行国家药品集中采购政策后文简称国家集采政策”)提供参考方法基于利益相关者理论并结合 文献研究访谈调研等方法对国家集采政策涉及的主要利益相关者—政府部门医药企业医疗机构和患者的角色定位利益诉求相互关系等方面进行分析结果与结论政府部门包括医保部门卫生健康部门药品监管部门和其他部门其策划主导了国家集采政策其主要利益诉求是确保政策有序执行中选品种在临床上的合理使用和供应保障等医药企业包括药品生产企业和药品流通企业其直接参与了国家集采政策药品生产企业的主要利益诉求是保证合理的利润以支持其产品研发促进企业转型等药品流通企业的主要利益诉求是希望获得品种配送权以提高企业的市场份额扩大营销的广度和深度获得经营利润等医疗机构作为医疗服务和药品的主要提供方负责执行国家集采政策中选结果其主要利益诉求是提高自身的知名度和美誉度患者是医疗服务和药品的需求方也是国家集采政策改革的主要受益者其主要利益诉求是降低用药负担同时能够保证所用药品是安全有效的为了国家集采政策更好地推进建议发挥政府的主导作用协同其他政策推进三医联动改革优化药品采 购机制引导市场价格的合理形成鼓励企业持续提升通过仿制药一致性评价品种的质量并强化质量监管
ABSTRACT:
OBJECTIVETo provide reference for the better implementation of National Drug Centralized Procurement Policy hereinafter referred to as theNational Centralized Procurement Policy”). METHODSBased on the stakeholder theorycombining with literature research and interview research methodsthe role orientationinterest demands and mutual relations of the main stakeholders involved in National Centralized Procurement Policysuch as government departmentspharmaceutical enterprisesmedical institutions and patients were analyzed. RESULTS & CONCLUSIONSGovernment departments include medical insurance departmenthealth departmentdrug supervision department and other departmentswhich plan and lead the National Centralized Procurement Policytheir main interest demand is to ensure the orderly implementation of the policythe rational use and supply guarantee of the selected varieties in clinicetc. Pharmaceutical enterprises include pharmaceutical production enterprises and pharmaceutical circulation enterpriseswhich directly participate in the National Centralized Procurement Policythe main interest demand of drug production enterprises is to ensure reasonable profits to support their product R&D and promote enterprise transformationthat of pharmaceutical circulation enterprises is to obtain the variety distribution rightso as to improve the market share of enterprisesexpand the breadth and depth of marketingand obtain operating profitsetc. As the main provider of medical services and drugsmedical institutions are responsible for implementing the selected category results of the National Centralized Procurement Policytheir main interest demand is to improve its own popularity and reputation. Patients are not only the demanders of medical services and drugsbut also the main beneficiaries of the reform of National Centralized Procurement Policytheir main interest demand is to reduce the drug burden and ensure that the drugs used are safe and effective. In order to better promote the National Centralized Procurement Policyit is suggested to give play to the leading role of the government and promote the reform oftripartite system reformin coordination with other policiesoptimize the drug procurement mechanism and guide the reasonable formation of market priceencourage enterprises to continuously improve the quality of varieties through generic drug consistency evaluationand strengthen quality supervision.
期刊: 2021年第32卷第21期
作者: 谢金平,张雪瑞,张 赫,杨伊凡,邵 蓉
AUTHORS: XIE Jinping,ZHANG Xuerui,ZHANG He,YANG Yifan,SHAO Rong
关键字: 国家药品集中采购政策;利益相关者;政府部门;医药企业;医疗机构;患者
KEYWORDS: National Drug Centralized Procurement Policy;Stakeholders;Government department;Pharmaceutical enterprise;
阅读数: 178 次
本月下载数: 20 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!